AI Ophthalmology and Optometry | Altris AI

Altris for Diabetic Retinopathy Research

How Altris Helps Research DR (RUO)

Book Intro AI Ophthalmology and Optometry | Altris AI

Altris IMS is an FDA-cleared (510(k)) image management system for OCT. Intended to support research workflows by enabling:

Identification and visualization of OCT imaging features commonly associated with DR, including diffusee edema, subretinal fluid, vitelliform material, intraretinal hyperreflective foci, as well as less frequently described features such as epiretinal fibrosis and retinal surface irregularities.
Quantitative measurements of selected DR-related imaging features, with spatial information presented on ETDRS-style maps and B-scan visualizations.
Automated comparisons of imaging data across multiple visits can be viewed through percentage-based displays, maps, and graphs.

For research use only. Not for diagnostic or clinical decision-making.

Platform overview

Only practical features for eye care specialists and clinical research

The security of patients’ data is our top priority: we are GDPR compliant, all data is encrypted, CE-certified, and FDA-cleared (510k) as an IMS system.

Alisdair Buchanan Optometry Owner, UK

"Altris IMS has significantly enhanced the way we work with OCT scans."

Jeff Sciberras Optometry Owner

"The introduction of OCT with Altris IMS has transformed my practice literally overnight. The integration was seamless and Altris customer support has been outstanding."

Clara Pereira Optometrist, Portugal

"Altris IMS gives me an extra layer of certainty."

Dr. Sundeep Kheterpal Surgeon

"We are very happy with the outstanding customer service and support."

The system provides tools for research-focused review of longitudinal OCT data for US retina studies to observe changes in image-derived features associated with diabetic retinopathy (DR). Thus, the Pathology Progression module offers quantitative, image-derived measurements of selected DR-related features, including fine-scale changes, to support research analysis.

Automated identification and visualization of imaging features associated with DR to support efficient image-review workflows.
Objective, quantitative measurements of DR-related imaging features for use in research.
Visualization of feature changes over time, supported by maps and graphical displays.
Longitudinal image-based data to assist with analysis and stratification activities in research settings. For research use only. Not for diagnostic or clinical decision-making.

Add OCT examinations from different visits

Label all the biomarkers of DR with color-coding

Explore DR biomarkers in terms of area, volume

Compare changes in DR biomarkers over time

How Altris IMS works?

What makes Altris IMS effective for Diabetic Retinopathy research?

Altris IMS is a web-based platform developed by professionals with expertise in retinal imaging. The system is built using a large collection of OCT scans, thousands of which have been manually annotated for research and development purposes. These data support AI-based image-analysis tools that can:

Visualize a wide range of OCT imaging features, including those associated with diabetic retinopathy (DR)

Provide quantitative, image-derived measurements of selected features for use in research analyses

Support longitudinal review of imaging features across multiple examinations through standardized visualizations

Offer structured, objective outputs to assist with research or investigational workflows

For research use only. Not for diagnostic or clinical decision-making.

Formats

DICOM format will help you to extract maximum information. However, the system works with all
data formats, such as jpg, and png

OCT equipment

Altris IMS is vendor-neutral. We work with the OCT data from 8 OCT manufacturers

OCT reports

We create comprehensible OCT reports for patients and eye care specialists based on historical research

For Pharma

For innovative approach in pharma

What you get:

Centralized OCT Data Management
Historical Data Analysis
Vendor-neutral analysis of OCT scans (8 manufacturers)
Data Security & Compliance
Additional capabilities for research
40+retinal biomarkers studied in research across 30+ retinal conditions. For Research Use Only. Not for diagnostic procedures.
Quantitative exploration of 40+biomarkers for Research Use Only. Not for diagnostic procedures.
Reports

For Eye Care

IMS for Ophthalmology and Optometry

What you get:

Centralized OCT Data Management
Vendor-Neutral OCT Compatibility (8 manufacturers)
Secure & Compliant Data Environment
Historical OCT Data Analysis
Seamless Clinical Workflow Integration
40+retinal biomarkers studied in research across 30+ retinal conditions. For Research Use Only. Not for diagnostic procedures.
Quantitative exploration of 40+biomarkers for Research Use Only. Not for diagnostic procedures.

Contact us

Ask us any question

Book intro + free trial

Demo